Cyanocobalamin Injection Recalled Due to Subpotency and Assay Non-Compliance
American Health Packaging is recalling Cyanocobalamin Injection because the product contains insufficient active ingredient and is out of specification for assay. The recalled lots (CCC210008, CCC210009) were distributed in Alabama.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall with no reported illnesses or injuries. The subpotency issue represents a product quality and efficacy concern rather than a direct safety hazard. Consequently, this meets the threshold for a Moderate severity rating per the rubric that indicates FDA Class III recalls are typically scored 1 or 2.
Plain-English summary
American Health Packaging is recalling Cyanocobalamin Injection, USP, 1000 mcg per mL, because the product is subpotent—its active ingredient concentration is below the specified level. The product is manufactured by Eugia Pharma Specialties Limited (Hyderabad, India) for BluePoint Laboratories.
Affected lots CCC210008 and CCC210009 (expiring January 2023) comprise approximately 97,975 vials that were distributed in Alabama. The product is supplied in cartons of 25 vials, with NDC numbers 68001-509-60 (carton) and 68001-509-59 (vial).
This is an FDA Class III drug recall.
The recalled product
- Product
- Cyanocobalamin Injection, USP, 1000 mcg per mL, For Intramuscular or Subcutaneous Use Only, 25 x 1 mL Vials, Rx only, Manufactured by: Eugia Pharma Specialties Limited, Hyderabad India for BluePoint Laboratories. NDC for Carton: 68001-509-60; NDC for vial: 68001-509-59
- Manufacturer
- American Health Packaging
- Category
- Drug — Vitamin B12
- Hazard
- subpotency
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lots: CCC210008
- CCC210009
- Exp. 01/23
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27